Opportunity Information: Apply for RFA AT 21 006
The NIH funding opportunity "Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)" (RFA-AT-21-006) is a cooperative agreement designed to build and coordinate research networks that can accelerate progress on understanding the neurocircuitry involved in force-based manipulations. In practical terms, the program is less about funding a single large, stand-alone research project and more about creating shared infrastructure, common concepts, and collaborative momentum across multiple investigators and disciplines. The central goal is to develop field-wide resources by refining and testing key ideas that will push the science forward, especially where the community needs better alignment on definitions, experimental approaches, and how neural mechanisms are interpreted in the context of mechanistic, force-applied interventions.
The initiative emphasizes network-building activities that strengthen a research area over time. Supported activities include convening meetings and conferences to bring researchers together, running small-scale pilot studies that can generate preliminary data or evaluate emerging concepts, and offering multidisciplinary cross-training programs. Examples of the cross-training emphasis include intensive workshops, summer institutes, and visiting scholar programs, all aimed at helping investigators and trainees learn methods and frameworks from adjacent fields (for instance, neuroscience, biomechanics, rehabilitation science, engineering, and clinical disciplines). The opportunity also explicitly highlights information dissemination as a supported activity, signaling that funded networks are expected to share knowledge broadly, promote standards or best practices where appropriate, and help cultivate a cohesive research community around the priority scientific areas referenced in the announcement.
From an administrative standpoint, this is a discretionary federal funding opportunity offered by the National Institutes of Health under a cooperative agreement mechanism (U24). A cooperative agreement typically means NIH program staff will have substantial involvement in the funded network's activities compared with a standard research grant, often through coordination, guidance, and participation in steering or advisory structures. The opportunity is categorized within the health funding activity area and is associated with CFDA numbers 93.213 and 93.853. The "clinical trial optional" label indicates applicants may propose work that includes a clinical trial, but they are not required to do so; the network can focus on preclinical, translational, or human-focused mechanistic work depending on what best supports the program's goals.
Eligibility is broad and includes many common U.S.-based applicant types: state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; tribal organizations that are not federally recognized; nonprofits (both 501(c)(3) and non-501(c)(3), as long as they are not higher education institutions in those categories); for-profit organizations other than small businesses; and small businesses. The notice also calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, Indian/Native American tribal governments other than federally recognized ones, and U.S. territories or possessions. At the same time, there are important restrictions regarding foreign participation: non-U.S. entities (foreign organizations and foreign institutions) are not eligible to apply, and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components are allowed as defined by the NIH Grants Policy Statement, which generally means a U.S. applicant organization may include certain foreign elements within a project under NIH rules, even though the main applicant must be domestic.
Key timing details from the source information include a creation date of March 23, 2021, and an original closing date of July 14, 2021. The provided record does not specify an award ceiling or the expected number of awards, so applicants would typically need to consult the full FOA text and any related NIH notices for budget and award planning details. Overall, the program is best read as an NIH effort to intentionally grow a coordinated research ecosystem around the neural mechanisms of force-based manipulations by funding the connective tissue of science: shared meetings, shared training, pilot data generation, and structured dissemination that can raise the rigor, comparability, and pace of discovery across the field.Apply for RFA AT 21 006
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Neural Mechanisms of Force-Based Manipulations: High Priority Research Networks (U24 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.213, 93.853.
- This funding opportunity was created on 2021-03-23.
- Applicants must submit their applications by 2021-07-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Power Africa Healthcare Facility Electrification Activity (HFE)
Previous opportunity: Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AT 21 006
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AT 21 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) Apply for PAR 21 143 Funding Number: PAR 21 143 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed) Apply for RFA RM 21 022 Funding Number: RFA RM 21 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Allowed) Apply for RFA RM 21 021 Funding Number: RFA RM 21 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial Not Allowed) Apply for RFA HG 21 007 Funding Number: RFA HG 21 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 009 Funding Number: RFA AI 21 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R01 Clinical Trial Not Allowed) Apply for RFA HG 21 006 Funding Number: RFA HG 21 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R43/R44) Apply for RFA HG 21 008 Funding Number: RFA HG 21 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) Apply for RFA AI 21 012 Funding Number: RFA AI 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) Apply for PAR 21 187 Funding Number: PAR 21 187 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2 Clinical Trial Not Allowed) Apply for RFA AR 21 016 Funding Number: RFA AR 21 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases, and Sjgrens Syndrome (UC2 Clinical Trial Optional) Apply for RFA AR 21 015 Funding Number: RFA AR 21 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) Apply for PAR 21 210 Funding Number: PAR 21 210 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) Apply for PAR 21 211 Funding Number: PAR 21 211 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) Apply for PAR 21 196 Funding Number: PAR 21 196 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) Apply for PAR 21 185 Funding Number: PAR 21 185 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 21 012 Funding Number: RFA RM 21 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Intramural - Extramural Collaboration for Drug Screening with Biofabricated 3-D Disease Tissue Models (UH2/UH3 Clinical Trial Not Allowed) Apply for RFA TR 21 015 Funding Number: RFA TR 21 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Radiation-Induced Immune Dysfunction (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 019 Funding Number: RFA AI 21 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Apply for PAR 21 197 Funding Number: PAR 21 197 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials) Apply for PA 21 214 Funding Number: PA 21 214 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AT 21 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
